- Home
- SWMR vs BBOT Comparison
SWMR vs BBOT Comparison
Compare SWMR & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWMR | BBOT |
|---|---|---|
| Founded | 2023 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.1M | 442.6M |
| IPO Year | 2026 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SWMR | BBOT |
|---|---|---|
| Price | $9.12 | $2.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $23.55 |
| AVG Volume (30 Days) | ★ 668.6K | 558.0K |
| Earning Date | 11-20-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.93 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,267.13 | N/A |
| Revenue Next Year | $490.28 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.45 | $2.60 |
| 52 Week High | $83.30 | $14.87 |
Technical Indicators
Market Signals| Indicator | SWMR | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 26.22 | 19.74 |
| Support Level | N/A | N/A |
| Resistance Level | $38.06 | $9.36 |
| Average True Range (ATR) | 0.91 | 0.21 |
| MACD | 0.45 | 0.10 |
| Stochastic Oscillator | 12.82 | 4.64 |
Price Performance
Historical ComparisonAbout SWMR Swarmer Inc Common Stock
Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.